(sum of all infusions from LGA sessions 1-12) * 20
Tags: Behavior · Heroin
Project: u01_peter_kalivas
1 loci · 1 genes with independent associations · 1 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | 11 | 34746237 | 36143622 | 1 | 1 | 2.66e-07 | 2.66e-07 | 1e+00 | Get1 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.26 |
Adipose | alternative TSS | 0 | 0 | 1.13 |
Adipose | gene expression | 0 | 0 | 1.17 |
Adipose | isoform ratio | 0 | 0 | 1.17 |
Adipose | intron excision ratio | 1 | 0 | 1.1 |
Adipose | mRNA stability | 0 | 0 | 1.15 |
BLA | alternative polyA | 0 | 0 | 1.32 |
BLA | alternative TSS | 0 | 0 | 1.12 |
BLA | gene expression | 0 | 0 | 1.2 |
BLA | isoform ratio | 0 | 0 | 1.23 |
BLA | intron excision ratio | 0 | 0 | 1.17 |
BLA | mRNA stability | 0 | 0 | 1.2 |
Brain | alternative polyA | 0 | 0 | 1.34 |
Brain | alternative TSS | 0 | 0 | 1.15 |
Brain | gene expression | 0 | 0 | 1.22 |
Brain | isoform ratio | 0 | 0 | 1.3 |
Brain | intron excision ratio | 0 | 0 | 1.17 |
Brain | mRNA stability | 0 | 0 | 1.18 |
Eye | alternative polyA | 0 | 0 | 1.32 |
Eye | alternative TSS | 0 | 0 | 1.16 |
Eye | gene expression | 0 | 0 | 1.16 |
Eye | isoform ratio | 0 | 0 | 1.08 |
Eye | intron excision ratio | 0 | 0 | 1.12 |
Eye | mRNA stability | 0 | 0 | 1.37 |
IL | alternative polyA | 0 | 0 | 1.43 |
IL | alternative TSS | 0 | 0 | 1.06 |
IL | gene expression | 0 | 0 | 1.21 |
IL | isoform ratio | 0 | 0 | 1.17 |
IL | intron excision ratio | 0 | 0 | 1.3 |
IL | mRNA stability | 0 | 0 | 1.27 |
LHb | alternative polyA | 0 | 0 | 1.32 |
LHb | alternative TSS | 0 | 0 | 1.37 |
LHb | gene expression | 0 | 0 | 1.18 |
LHb | isoform ratio | 0 | 0 | 1.26 |
LHb | intron excision ratio | 0 | 0 | 1.11 |
LHb | mRNA stability | 0 | 0 | 1.17 |
Liver | alternative polyA | 0 | 0 | 1.17 |
Liver | alternative TSS | 0 | 0 | 1.16 |
Liver | gene expression | 0 | 0 | 1.21 |
Liver | isoform ratio | 0 | 0 | 1.2 |
Liver | intron excision ratio | 0 | 0 | 1.16 |
Liver | mRNA stability | 0 | 0 | 1.19 |
NAcc | alternative polyA | 0 | 0 | 1.33 |
NAcc | alternative TSS | 0 | 0 | 1.15 |
NAcc | gene expression | 0 | 0 | 1.19 |
NAcc | isoform ratio | 0 | 0 | 1.22 |
NAcc | intron excision ratio | 0 | 0 | 1.19 |
NAcc | mRNA stability | 0 | 0 | 1.16 |
OFC | alternative polyA | 0 | 0 | 1.3 |
OFC | alternative TSS | 0 | 0 | 1.18 |
OFC | gene expression | 0 | 0 | 1.27 |
OFC | isoform ratio | 0 | 0 | 1.2 |
OFC | intron excision ratio | 0 | 0 | 1.26 |
OFC | mRNA stability | 0 | 0 | 1.29 |
PL | alternative polyA | 0 | 0 | 1.37 |
PL | alternative TSS | 0 | 0 | 1.2 |
PL | gene expression | 0 | 0 | 1.2 |
PL | isoform ratio | 0 | 0 | 1.26 |
PL | intron excision ratio | 0 | 0 | 1.21 |
PL | mRNA stability | 0 | 0 | 1.18 |